Rossari Biotech Limited (ROSSARI) — Board Meeting
The Board approved unaudited Q1 FY2026 results showing revenue of [amount not verified], profit after tax of [amount context mismatch] crores, and a restructuring that will transfer 100% of Rossari International to Rossari (Singapore) Pte. Ltd. The ESOP grant of 4,000 options at ₹531 each and allotment of 2,500 shares raised paid‑up capital to [amount not verified]. The sale of 9,000 RILC shares at ~₹24 crores awaits Saudi approval, with completion targeted for March 31, 2027.
About Rossari Biotech Limited (ROSSARI)
Chemicals · Chemicals & Petrochemicals · Listed on NSE
📡 Get AI alerts when ROSSARI files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ROSSARI — Free💡 Ask AI about this filing
📊 More ROSSARI filings
- Announcement — 20 July 2026 Rossari Biotech announced that the audio recording of its Q1 FY27 earnings conference call held on J...
- 🟡 Board Meeting — 20 July 2026 Rossari Biotech corrected a typographical error in its July 18 board meeting announcement, changing ...
- 🟡 Board Meeting — 20 July 2026 Rossari Biotech held its 17th AGM on July 20, 2026 via video conferencing, where all 8 resolutions w...
- 🔴 Financial Results — 19 July 2026 Rossari Biotech reported consolidated revenue of Rs. 697.2 crore for Q1 FY27, up 28% YoY, with EBITD...
- 🔴 Financial Results — 19 July 2026 Rossari Biotech reported record Q1 FY27 revenue of ₹697.2 crores, up 28.2% YoY, driven by strong per...
🔥 Also filed on 18 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ROSSARI files new disclosures
Track ROSSARI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ROSSARI — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research